| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Division of Cardiothoracic Surgery (Drs. Handy, Douville, Tsen, and Ott, and Ms. Koh), The Oregon Clinic, Portland, OR; the Earle A. Chiles Research Institute (Dr. Asaph), Providence Portland Medical Center, Portland, OR; the Center for Outcomes Research and Education (Dr. Skokan), Providence Health Systems, Portland, OR; the Divisions of Cardiothoracic Surgery, Pulmonary and Critical Care Medicine, and The Center for Health Care Research (Drs. Reed, Brooks, and Silvestri), Medical University of South Carolina, Charleston, SC.
Correspondence to: John R. Handy Jr., MD, FCCP, Division of Cardiothoracic Surgery, The Oregon Clinic, 507 NE 47th Ave, Portland, OR, 97213; e-mail: jhandy{at}orclinic.com
Objective: To compare baseline preoperative and 6-month postoperative functional health status and quality of life in patients undergoing lung cancer resection.
Methods: Lung cancer surgery patients from three hospitals were administered the Short-Form 36 Health Survey (SF-36) and the Ferrans and Powers’ quality-of-life index (QLI) before surgery and 6 months after surgery. Preoperative, intraoperative, hospital stay, and 6-month postoperative clinical data were collected. All p values 
0.05 were considered significant.
Results: One hundred thirty-nine patients were studied; 131 patients were discharged and 8 patients (5.8%) died. One hundred three patients (78.6%) who survived underwent an evaluation at 6 months, 16 patients (12.2%) died during follow-up, 2 patients refused follow-up, 4 patients were unavailable for follow-up, and 6 patients are awaiting an evaluation at 6 months. Compared with matched healthy subjects, preoperative lung cancer patients had worse results on the SF-36 physical functioning, role–emotional, mental health, and energy subscales. At 6 months, SF-36 subscales for physical functioning, role–physical, bodily pain, and mental health were significantly worse than preoperative values. The visual analog pain scale was significantly worse at follow-up. The QLI with all subscales and SF-36 for role–emotional, energy, and general health subscales were unaffected by lung cancer resection. Whereas preoperative FEV1 and 6-min walk results did not predict postoperative functional health status or QLI, a low preoperative diffusion capacity of the lung for carbon monoxide (DLCO) predicted poor postoperative QLI. Preoperative chemoradiation, extent of resection, postoperative complications, or adjuvant therapy did not negatively affect the results of the 6-month QLI or SF-36.
Conclusions: Preoperative functional health status in patients who undergo lung cancer surgery is significantly impaired. A significant number of patients die during the 6 months after surgery. Pain and impairment of functional health status persists for 6 months after lung cancer resection. DLCO, not FEV1, predicts postoperative quality of life. Preoperative chemoradiation, extent of resection, postoperative complications, or adjuvant therapy do not adversely affect functional health status or quality of life 6 months after surgery. Future studies should focus on risk prediction, technical improvements, and postoperative intervention to improve the functional outcomes and quality of life after lung cancer surgery.
Key Words: functional health status • lung cancer surgery • outcomes • quality of life
This article has been cited by other articles:
|
|
 |
|
  F. Barlesi, C. Doddoli, A. Loundou, E. Pillet, P. Thomas, and P. Auquier Preoperative psychological global well being index (PGWBI) predicts postoperative quality of life for patients with non-small cell lung cancer managed with thoracic surgery. Eur. J. Cardiothorac. Surg., September 1, 2006; 30(3): 548 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J-E C Holty and M K Gould When in doubt should we cut it out? The role of surgery in non-small cell lung cancer. Thorax, July 1, 2006; 61(7): 554 - 556. [Full Text] [PDF]
|
|
|
|
|
|
A. Brunelli, M. A. Refai, M. Salati, A. Sabbatini, N. J. Morgan-Hughes, and G. Rocco Carbon monoxide lung diffusion capacity improves risk stratification in patients without airflow limitation: evidence for systematic measurement before lung resection. Eur. J. Cardiothorac. Surg., April 1, 2006; 29(4): 567 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. F. Meyers, F. Haddad, B. A. Siegel, J. B. Zoole, R. J. Battafarano, N. Veeramachaneni, J. D. Cooper, and G. A. Patterson Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer J. Thorac. Cardiovasc. Surg., April 1, 2006; 131(4): 822 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rossi, R. Dore, A. Cascina, V. Vespro, F. Garbagnati, L. Rosa, V. Ravetta, A. Azzaretti, P. Di Tolla, G. Orlandoni, et al. Percutaneous computed tomography-guided radiofrequency thermal ablation of small unresectable lung tumours. Eur. Respir. J., March 1, 2006; 27(3): 556 - 563. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Abou-Jawde, T. Mekhail, D. J. Adelstein, L. A. Rybicki, P. J. Mazzone, M. A. Caroll, and T. W. Rice Impact of Induction Concurrent Chemoradiotherapy on Pulmonary Function and Postoperative Acute Respiratory Complications in Esophageal Cancer Chest, July 1, 2005; 128(1): 250 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. F. Lausberg, T. P. Graeter, D. Tscholl, O. Wendler, and H.-J. Schafers Bronchovascular Versus Bronchial Sleeve Resection for Central Lung Tumors Ann. Thorac. Surg., April 1, 2005; 79(4): 1147 - 1152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T Win, L Sharples, F C Wells, A J Ritchie, H Munday, and C M Laroche Effect of lung cancer surgery on quality of life Thorax, March 1, 2005; 60(3): 234 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Esteva Surgery in Lung Cancer Patients Chest, August 1, 2004; 126(2): 656 - 656. [Full Text] [PDF]
|
|
|
|
|
|
A. Toker, S. Dilege, S. Ziyade, O. Eroglu, S. Tanju, D. Yilmazbayhan, Z. Kilicarslan, and G. Kalayci Causes of death within 1 year of resection for lung cancer. Early mortality after resection Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 515 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Ferguson and A. G. Lehman Sleeve lobectomy or pneumonectomy: optimal management strategy using decision analysis techniques Ann. Thorac. Surg., December 1, 2003; 76(6): 1782 - 1788. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Ferguson Optimal management when unsuspected N2 nodal disease is identified during thoracotomy for lung cancer: cost-effectiveness analysis J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1935 - 1942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Suh, A. B. Wallace, R. E. Sheehan, S. B. Heinze, and J. G. Goldin Unresectable Pulmonary Malignancies: CT-guided Percutaneous Radiofrequency Ablation--Preliminary Results Radiology, December 1, 2003; 229(3): 821 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J M Maskill, A Rother, and S Seevanayagam Transoesophageal echocardiography and lung cancer staging Thorax, August 1, 2003; 58(8): 735 - 735. [Full Text] [PDF]
|
|
|
|
|
|
K McManus Concerns of poor quality of life should not deprive patients of the opportunity of curative surgery Thorax, March 1, 2003; 58(3): 189 - 189. [Full Text] [PDF]
|
|
|
|
 |
|
 Minerva BMJ, August 24, 2002; 325(7361): 450 - 450. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
